new biotech drug for rheumatoid arthritis called Orencia (oh-REN-see-ah)

You'll hear about a new biotech drug for rheumatoid arthritis called Orencia (oh-REN-see-ah).

Orencia (abatacept) is an immune modulator. It inhibits T-cell activation...but it works "upstream" from where TNF blockers work.

This means that Orencia reduces the PRODUCTION of tumor necrosis factor plus other immune modulators. But it's not known if this mechanism improves efficacy.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote